- Apr 2, 2009
- 5,171
- 13,288
- 66
US Appeals Court panel upholds NYC ban on some flavored OTP
http://www.ca2.uscourts.gov/decisio...4c6f-953b-e7ff83d1e74a/1/doc/11-5167c_opn.pdf
Wednesday, February 27 | Talk Radio News ServiceTalk Radio News Service
The following excerpt (on pages 3-4) of this court ruling presents an excellent summary of the legal limitations and requirements for the FDA to propose/approve new regulations for tobacco products (under Chapter IX of the FSPTCA).
If/when the FDA proposes the "deeming" regulation (to regulate e-cigarettes, cigars and other products under Chapter IX provisions), the agency has stated that it also intends to propose additional regulations (presumably that would ban e-cigarette sales to minors, require warning labels, restrict nicotine levels, advertising, promotions, sponsorships, sales, and/or flavorings).
Seems like some/many of the requirements in the third paragraph (below) for FDA to consider when proposing/approving new regulations for e-cigarettes cannot be met unless the FDA grossly misrepresents the evidence on e-cigarettes.
The Family Smoking Prevention and tobacco Control Act
Congress enacted the FSPTCA in 2009 to grant the Food and Drug Administration
(FDA) authority to regulate tobacco products under the Food, Drug, and Cosmetic Act,
21 U.S.C. § 301 et seq. See 21 U.S.C. § 387a(a). Under the Act, the FDAs authority
extends to the regulation of all cigarettes, cigarette tobacco, roll-your-own tobacco, and
smokeless tobacco and to any other tobacco products that the [FDA] by regulation deems
to be subject to [the Act]. Id. § 387a(b).
Of particular relevance to the present action is § 907 of the FSPTCA. Entitled
Tobacco Product Standards, it sets out a special rule for cigarettes, which provides
that a cigarette or any of its component parts . . . shall not contain, as a constituent . . . or
additive, an artificial or natural flavor (other than tobacco or menthol) or an herb or
spice. Id. § 387g(a)(1)(A). Section 907 further grants the FDA authority to revise the
special rule for cigarettes, id. § 387g(a)(2), and to adopt additional product standards if
appropriate for the protection of the public health, id. § 387g(a)(3)(A). Specifically,
the FDA is authorized to establish standards respecting the construction, components,
ingredients, additives, constituents, including smoke constituents, and properties of . . .
tobacco product, id. § 387g(a)(4)(B)(i), and to adopt provisions restricting their sale
3and distribution, id. § 387g(a)(4)(B)(v). The FDA may not, however, ban[] all
cigarettes, all smokeless tobacco products, all little cigars, all cigars other than little
cigars, all pipe tobacco, or all roll-your-own tobacco products, or requir[e] the
reduction of nicotine yields of a tobacco product to zero. Id. § 387g(d)(3).
Before imposing restrictions on the sale and distribution of a tobacco product,
the FDA must determine that such regulation would be appropriate for the protection of
the public health. Id. § 387f(d)(1). In deciding whether a regulation is appropriate, the
FDA must consider the risks and benefits to the population as a whole, including users
and nonusers of the tobacco product. Id. Specifically, the FDA must take into account
the increased or decreased likelihood that existing users of tobacco products will stop
using such products, as well as the increased or decreased likelihood that those who do
not use tobacco products will start using such products. Id. § 387f(d)(1)(A), (B).
Finally, the FDA may not prohibit the sale of any tobacco product in face-to-face
transactions by a specific category of retail outlets; or . . . establish a minimum age of sale
of tobacco products to any person older than 18 years of age. Id. § 387f(d)(3)(A).
http://www.ca2.uscourts.gov/decisio...4c6f-953b-e7ff83d1e74a/1/doc/11-5167c_opn.pdf
Wednesday, February 27 | Talk Radio News ServiceTalk Radio News Service
The following excerpt (on pages 3-4) of this court ruling presents an excellent summary of the legal limitations and requirements for the FDA to propose/approve new regulations for tobacco products (under Chapter IX of the FSPTCA).
If/when the FDA proposes the "deeming" regulation (to regulate e-cigarettes, cigars and other products under Chapter IX provisions), the agency has stated that it also intends to propose additional regulations (presumably that would ban e-cigarette sales to minors, require warning labels, restrict nicotine levels, advertising, promotions, sponsorships, sales, and/or flavorings).
Seems like some/many of the requirements in the third paragraph (below) for FDA to consider when proposing/approving new regulations for e-cigarettes cannot be met unless the FDA grossly misrepresents the evidence on e-cigarettes.
The Family Smoking Prevention and tobacco Control Act
Congress enacted the FSPTCA in 2009 to grant the Food and Drug Administration
(FDA) authority to regulate tobacco products under the Food, Drug, and Cosmetic Act,
21 U.S.C. § 301 et seq. See 21 U.S.C. § 387a(a). Under the Act, the FDAs authority
extends to the regulation of all cigarettes, cigarette tobacco, roll-your-own tobacco, and
smokeless tobacco and to any other tobacco products that the [FDA] by regulation deems
to be subject to [the Act]. Id. § 387a(b).
Of particular relevance to the present action is § 907 of the FSPTCA. Entitled
Tobacco Product Standards, it sets out a special rule for cigarettes, which provides
that a cigarette or any of its component parts . . . shall not contain, as a constituent . . . or
additive, an artificial or natural flavor (other than tobacco or menthol) or an herb or
spice. Id. § 387g(a)(1)(A). Section 907 further grants the FDA authority to revise the
special rule for cigarettes, id. § 387g(a)(2), and to adopt additional product standards if
appropriate for the protection of the public health, id. § 387g(a)(3)(A). Specifically,
the FDA is authorized to establish standards respecting the construction, components,
ingredients, additives, constituents, including smoke constituents, and properties of . . .
tobacco product
3and distribution, id. § 387g(a)(4)(B)(v). The FDA may not, however, ban[] all
cigarettes, all smokeless tobacco products, all little cigars, all cigars other than little
cigars, all pipe tobacco, or all roll-your-own tobacco products, or requir[e] the
reduction of nicotine yields of a tobacco product to zero. Id. § 387g(d)(3).
Before imposing restrictions on the sale and distribution of a tobacco product,
the FDA must determine that such regulation would be appropriate for the protection of
the public health. Id. § 387f(d)(1). In deciding whether a regulation is appropriate, the
FDA must consider the risks and benefits to the population as a whole, including users
and nonusers of the tobacco product. Id. Specifically, the FDA must take into account
the increased or decreased likelihood that existing users of tobacco products will stop
using such products, as well as the increased or decreased likelihood that those who do
not use tobacco products will start using such products. Id. § 387f(d)(1)(A), (B).
Finally, the FDA may not prohibit the sale of any tobacco product in face-to-face
transactions by a specific category of retail outlets; or . . . establish a minimum age of sale
of tobacco products to any person older than 18 years of age. Id. § 387f(d)(3)(A).